Sommaire

• • ·Pulmonary embolism thrombolysis: Do we need another agent?

    Page :1-2

    Samuel Z. Goldhaber

    
• • ·Steroids for restenosis: Strike three!

    Page :3-4

    David F. Kong

     
• • ·Contemporary issues in heart failure

    Page :5-8

    Jalal K. Ghali

    Plan Plan
• • ·Pandora’s box is torn asunder

    Page :9-12

    Allan S. Jaffe

    
• • ·Alternate-day dosing of aspirin in atrial fibrillation: A critical evaluation

    Page :13

    Christopher J. Howes, Michael D. Ezekowitz

    
• • ·Heart failure: A case for subspecialized care management

    Page :14-16

    John J. Smith, Marvin A. Konstam

    
• • ·Treatment of type III hyperlipoproteinemia

    Page :17-18

    John R. Guyton

    
• • ·Second harmonic imaging: Good reverberations

    Page :19-20

    Linda J. Crouse, Paul H. Kramer

    
• • ·Cardiogenic shock complicating acute myocardial infarction: Predictors of death

    Page :21-31

    David Hasdai, David R. Holmes, Robert M. Califf, Trevor D. Thompson, Judith S. Hochman, Matthias Pfisterer, Eric J. Topol, For the GUSTO-I Investigators

    Résumé Résumé Plan Plan
• • ·A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction

    Page :32-38

    Amos Katz, Idit F. Liberty, Avi Porath, Ilya Ovsyshcher, Eric N. Prystowsky

    Résumé Résumé Plan Plan  
• • ·Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism

    Page :39-44

    Ulrich Tebbe, Andreas Graf, Wolfram Kamke, Ralf Zahn, Florian Forycki, Gerhard Kratzsch, Günther Berg

    Résumé Résumé Plan Plan  
• • ·Prehospital testing for troponin T in patients with suspected acute myocardial infarction

    Page :45-48

    Andreas Schuchert, Christian Hamm, Jens Scholz, Stefanie Klimmeck, Britta Goldmann, Thomas Meinertz

    Résumé Résumé Plan Plan
• • ·Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention

    Page :49-54

    George Dangas, Jonathan D. Marmur, Traci E. King, Joshua De Leon, Samin K. Sharma, Raghuraman Vidhun, Dmitriy Feldman, Michael Y. Stoynov, Juan J. Badimon, John A. Ambrose

    Résumé Résumé Plan Plan  
• • ·Direct coronary stenting without balloon predilation in acute coronary syndromes

    Page :55-59

    Martial Hamon, Yves Richardeau, Emmanuel Lécluse, Eric Saloux, Rémi Sabatier, Denis Agostini, Jean-Emmanuel Filmont, Gilles Grollier, Jean-Claude Potier

    Résumé Résumé Plan Plan  
• • ·Prospective randomized trial of corticosteroids for the prevention of restenosis after intracoronary stent implantation

    Page :60-63

    Cheol Whan Lee, Jei-Kun Chae, Hee-Young Lim, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park

    Résumé Résumé Plan Plan
• • ·Administration of protamine after coronary stent deployment

    Page :64-68

    Carlo Briguori, Carlo Di Mario, Joseph De Gregorio, Imad Sheiban, Marco Vaghetti, Antonio Colombo

    Résumé Résumé Plan Plan
• • ·Effect of clinical factors on length of stay after coronary artery bypass surgery: Results of the Cooperative Cardiovascular Project

    Page :69-77

    Allison B. Rosen, J.O’Neal Humphries, Lawrence H. Muhlbaier, Catarina I. Kiefe, Timothy Kresowik, Eric D. Peterson

    Résumé Résumé Plan Plan  
• • ·Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

    Page :78-86

    Christopher M. O'Connor, Wendy A. Gattis, Barry F. Uretsky, Kirkwood F. Adams, Steven E. McNulty, Steven H. Grossman, William J. McKenna, Faiez Zannad, Karl Swedberg, Mihai Gheorghiade, Robert M. Califf, For the FIRST Investigators

    Résumé Résumé Plan Plan  
• • ·Insights into the contemporary epidemiology and outpatient management of congestive heart failure

    Page :87-94

    Finlay A. McAlister, Koon K. Teo, Muba Taher, Terrence J. Montague, Dennis Humen, Lawrence Cheung, Mercedeh Kiaii, Rita Yim, Paul W. Armstrong

    Résumé Résumé Plan Plan  
• • ·A novel biochemical approach to congestive heart failure: Cardiac troponin T

    Page :95-99

    Emil Missov, Johannes Mair

    Résumé Résumé Plan Plan
• • ·Self-reported differences between cardiologists and heart failure specialists in the management of chronic heart failure

    Page :100-107

    David Bello, Nihir B. Shah, Martin E. Edep, Ida M. Tateo, Barry M. Massie

    Résumé Résumé Plan Plan
• • ·Actual failure rates: A method of assessing tissue valve reoperation rates

    Page :108-113

    Steven Khan, Alfredo Trento, Robert Kass, Michele DeRobertis, Meenu Sandhu, Sharon Nessim

    Résumé Résumé Plan Plan  
• • ·Complications of Inoue balloon mitral commissurotomy: Impact of operator experience and evolving technique

    Page :114-121

    Jui-Sung Hung, Kean-Wah Lau, Ping-Han Lo, Ming-Shyan Chern, Jong-Jen Wu

    Résumé Résumé Plan Plan  
• • ·Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study

    Page :122-127

    Elaine M. Urbina, Samuel S. Gidding, Weihang Bao, Abdalla Elkasabany, Gerald S. Berenson

    Résumé Résumé Plan Plan  
• • ·Electrophysiologic procedures and activation of the hemostatic system

    Page :128-132

    Antonio Michelucci, Emilia Antonucci, Andrea A. Conti, Agatina Alessandrello Liotta, Sandra Fedi, Luigi Padeletti, Maria Cristina Porciani, Domenico Prisco, Rosanna Abbate, Gian Franco Gensini

    Résumé Résumé Plan Plan
• • ·Comparison of bipolar and integrated sensing for redetection of ventricular fibrillation

    Page :133-136

    Michael Cooklin, Rangarao V. Tummala, Robert W. Peters, Stephen R. Shorofsky, Michael R. Gold

    Résumé Résumé Plan Plan  
• • ·Alternate-day dosing of aspirin in atrial fibrillation

    Page :137-143

    Ignacio S. Posada, Vicente Barriales, For the LASAF Pilot Study Group

    Résumé Résumé Plan Plan  
• • ·Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery

    Page :144-150

    Joseph D. Redle, Sandeep Khurana, Rey Marzan, Peter A. McCullough, James R. Stewart, Douglas C. Westveer, William W. O'Neill, Joseph S. Bassett, Nicholas A. Tepe, Howard I. Frumin

    Résumé Résumé Plan Plan  
• • ·Long-term safety and efficacy of combination gemfibrozil and HMG-CoA reductase inhibitors for the treatment of mixed lipid disorders

    Page :151-155

    David K. Murdock, Anthony K. Murdock, Robert W. Murdock, Karen J. Olson, Arlyne M. Frane, Mary E. Kersten, Diane M. Joyce, Sue E. Gantner

    Résumé Résumé Plan Plan
• • ·Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia

    Page :156-162

    Fernando Civeira, Ana Cenarro, Juan Ferrando, José Puzo, Angel L. Garcia-Otín, Pilar Mozas, Miguel Pocoví

    Résumé Résumé Plan Plan  
• • ·Improved endocardial visualization with second harmonic imaging compared with fundamental two-dimensional echocardiographic imaging

    Page :163-168

    Roxy Senior, Prem Soman, Rajdeep S. Khattar, Avijit Lahiri

    Résumé Résumé Plan Plan  
• • ·Effects of endurance exercise training on left ventricular systolic performance and ventriculoarterial coupling in patients with coronary artery disease

    Page :169-174

    Morton R. Rinder, Tom R. Miller, Ali A. Ehsani

    Résumé Résumé Plan Plan  
• • ·Highlights from the American College of Cardiology 48th Annual Scientific Sessions: March 7 to 10, 1999

    Page :175-190

    John H. Alexander, Sana Al-Khatib, Warren Cantor, Adam B. Greenbaum, Michael P. Hudson, David F. Kong, Monica Shah